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Bioengineering functional smooth 
muscle with spontaneous rhythmic 
contraction in vitro
Masae Kobayashi1, Hassan A. Khalil2, Nan Ye Lei1,2, Qianqian Wang1, Ke Wang3, 
Benjamin M. Wu1,4 & James C. Y. Dunn1,2,5
Oriented smooth muscle layers in the intestine contract rhythmically due to the action of interstitial 
cells of Cajal (ICC) that serve as pacemakers of the intestine. Disruption of ICC networks has been 
reported in various intestinal motility disorders, which limit the quality and expectancy of life. A 
significant challenge in intestinal smooth muscle engineering is the rapid loss of function in cultured 
ICC and smooth muscle cells (SMC). Here we demonstrate a novel approach to maintain the function of 
both ICC and SMC in vitro. Primary intestinal SMC mixtures cultured on feeder cells seeded electrospun 
poly(3-caprolactone) scaffolds exhibited rhythmic contractions with directionality for over 10 weeks 
in vitro. The simplicity of this system should allow for wide usage in research on intestinal motility 
disorders and tissue engineering, and may prove to be a versatile platform for generating other types of 
functional SMC in vitro.
The intestine is responsible for digestion, nutrient and water absorption, and waste removal. An increasing num-
ber of people are suffering from various intestinal disorders which severely affect their life expectancy and qual-
ity of life1. According to the Crohn’s and Colitis Foundation of America, there are approximately 1.6 million 
Americans suffering from inflammatory bowel disease in 2014, which is a 0.2 million increase from 2008.
When the intestine fails to function, current medical treatment options have significant limitations: total par-
enteral nutrition leads to unacceptably high morbidity and mortality rates and transplantation faces donor scar-
city, organ rejection, and life-long immunosuppression2. Therefore, engineering functional intestinal tissue raises 
hope as an alternative therapeutic strategy for patients with intestinal failure. Previous studies have been done to 
regenerate the intestinal epithelium3,4 and many types of muscle, including vascular smooth muscle5,6, cardiac7–10 
and skeletal muscle5,11. However, few have investigated the regeneration of intestinal smooth muscle12,13.
The aligned smooth muscle layers of the intestine move autonomously. Spontaneous electrical slow waves 
derived from pacemaker activity of the intestine arrange contractile patterns into phasic contractions that are 
the basis for peristalsis. Neural or hormonal inputs do not generate the intrinsic pacemaker activity of smooth 
muscles but affect the degree of coupling between pacemaker activity and contractions14. Interstitial cells of Cajal 
(ICC) are a specialized group of cells responsible for the pacemaker activity in visceral smooth muscles, generat-
ing and actively propagating the slow waves15,16.
Isolated intestinal SMCs may generate fast Ca2+ action potentials, but not the spontaneous slow waves in 
smooth muscles. Conversely, isolated ICC generate spontaneous electrical rhythmicity similar to the electrical 
activity in intact smooth muscles17,18. The binding of stem cell factor (SCF) to the receptor tyrosine kinase Kit 
induces a signaling pathway in ICC, which is critical for the normal development of ICC and rhythmic activ-
ity19–23. SCF stimulation of Kit is essential for ICC maintenance22,24, and Ca2+ activated Cl− channels (Ano1) 
expressed on ICC were identified as the key conductance responsible for the pacemaker activity18. However, ICC 
comprise less than 10% of the cells within intestinal smooth muscle, and isolated ICC are difficult to maintain 
in cell culture. ICC tend to lose their characteristic morphologies and Kit immunoreactivity after enzymatic 
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digestion during the cell isolation procedure. Although ICC can grow and develop networks that produce elec-
trical rhythmicity in cell culture, those dispersed ICC undergo extensive phenotypic changes within a few days, 
including the apparent loss of the ion channels responsible for the slow wave activity14,18,25,26.
STO cells are embryonic fibroblasts commonly used for embryonic stem cell and primordial germ cell cul-
tures27–29 due to its potent growth factors and cytokines production ability including SCF30 essential for ICC. 
Using this STO feeder cell system, we demonstrate a novel protocol where both purified ICC and isolated intes-
tinal smooth muscle cell (ISMC) mixtures can be cultured for weeks in vitro with intact pacemaker ability and 
rhythmic contractions. Disruption of ICC networks and the loss of SMC maturity in intestinal muscularis have 
been reported in a variety of diseases resulting in intestinal motility disorders leading to pseudo-obstruction, 
Hirschsprung’s disease, inflammatory bowel diseases, and slow transit constipation31–34. Therefore, this system 
provides not only crucial progress in intestinal smooth muscle engineering, but also an in vitro platform to inves-
tigate cellular phenotypes and mechanisms associated with different intestinal disorders, to screen drugs that may 
alter motility, and to identify the biomarkers for early diagnosis and clinical stratification.
Moreover, this system may assist in maintaining and enhancing the maturity of SMCs from other vesicular 
organs, including the bladder, uterus, and vasculatures, due to their similar phenotypes35,36.
Results
ICC proliferation in vitro. To enrich the ICC population in culture, immunomagnetic sorting was per-
formed on primary intestinal smooth muscle cell mixture (ISMC Mix, derived from C57BL/6 mouse) that were 
first cultured on gelatin for 3 days. The resultant MACS+ cells (MACS purified ICC population using antibody to 
Kit) proliferated on mitomycin-treated STO cells that expressed stem cell factor (SCF). The MACS+ cells exhib-
ited ICC morphology and expressed Kit and Ano1 for up to two weeks in culture (Fig. 1a,b). When a 60 k per well 
cell seeding density was used, MACS+ cells spread on STO cells in 48-well plates and became confluent in one 
week. A lower seeding density was tested to achieve more cell expansion. MACS+ cells with seeding density of 15 
k proliferated on STO cells and formed a confluent layer in two week (Fig. 1a,b).
Since STO cells are embryonic fibroblasts commonly used for embryonic stem cell culture, embryonic fibro-
blasts derived from the same mouse strain as ISMC Mix (C57BL/6), MEF, were also tested with MACS+ cell 
culture, with gelatin-coated wells serving as controls. STO cells supported MACS+ cell growth better than gelatin 
coating and MEF cells (Fig. 1c–e). Although MACS+ cells proliferated on all three conditions (Fig. 1d), cells 
maintained the ICC marker Kit significantly better on STO cells (3.01 ± 0.347) than on MEF (0.442 ± 0.133) 
or gelatin(0.395 ± 0.150) (Fig. 1c,e and Supplementary Fig. 1). Although with the same 100 k cell seeding 
density, more STO cells than MEF were attached because the size of STO cells (1.00 ± 0.213) is smaller than 
MEF (5.05 ± 3.03) (Supplementary Fig. 2a,c). STO cells expressed significantly higher kitl mRNA level at day 
0 (0.24 ± 0.026 vs. 0.042 ± 0.002) and after 7 days (1.56 ± 0.121 vs. 1.09 ± 0.069) in culture than MEF cells 
(Supplementary Fig. 2d,e). STO cells also expressed more SCF protein at day 7 than MEF cells (Supplementary 
Fig. 2b). The difference in SCF expression may be responsible for the difference in ICC survival. This is further 
supported by varying STO cell density, which demonstrated a density-dependent proliferation of MACS+ cells30 
(Fig. 1f).
Exogenously added SCF, however, was insufficient to support ICC survival. Concentrations up to 100 ng/ml 
of free SCF added to the culture medium failed to preserve ICC phenotype (Fig. 1g). There may be additional 
factors secreted by STO cells that are beneficial for ICC growth. When STO conditioned media (CM) was mixed 
into the culture medium (1:1 ratio) for MACS+ cell culture, CM provided a cell density dependent benefit to 
MACS+ cells. CM provided significant improvement in MACS +cell growth on gelatin only at a lower seeding 
density (0.445 ± 0.097 vs. 0.191 ± 0.047) compared to control (Fig. 1h). Providing CM to a low seeding density 
(0.445 ± 0.097), MAC+ cells expressed Kit to a level comparable to MACS+ cells seeded at higher density with-
out CM (0.429 ± 0.140) (Fig. 1h).
The cultured MACS+ cells were passaged by performing an additional sorting on MACS+ cells growing on 
STO cells. Such passaged MACS+ cells (P-MACS+ cells) were seeded again on STO cells. Although the growth 
rate was slower, P-MACS+ cells also proliferated on STO cells and exhibited ICC morphology and expressed Kit 
and Ano1 (Fig. 2a–c).
Rhythmic pacemaker activity of cultured ICC (MACS+ and P-MACS+ cells). To determine 
whether cells cocultured with STO cells were functional, we examined the intracellular Ca2+ oscillation frequency 
in MACS+ and P-MACS+ cells cultured on STO cells or gelatin at different density. With a higher seeding den-
sity (60 k), the MACS+ cells on STO cells exhibited a rhythmic Ca2+ oscillation frequency that was significantly 
higher (0.241 ± 0.048 Hz vs. 0.078 ± 0.021 Hz) than MACS+ cells cultured on gelatin (Fig. 2d). STO cells also 
supported P-MACS+ cells seeded at a higher density, and these cells exhibited a rhythmic Ca2+ oscillation fre-
quency similar (0.249 ± 0.037 Hz vs. 0.241 ± 0.048 Hz) to MACS+ cells before passaging (Fig. 2e). Moreover, it’s 
easier to maintain and restore the functionality of MACS+ cells seeded at a higher density. With a lower seeding 
density (15 k), it was still possible to recover the functionality of MACS+ cells, but it took a longer culture time 
(day14 vs. day7) and resulted in slightly slower frequency (0.191 ± 0.029 Hz vs. 0.241 ± 0.048 Hz) than a higher 
seeding density (60 k) (Fig. 2e). The number of functional cells in P-MACS+ culture was about half of that in 
MACS+ culture due to a slower growth rate (Fig. 2a–c). A higher seeding density and lower passage number were 
beneficial for cells to form a network sooner, which lead to an earlier establishment of coordinated pacemaker 
activity in culture (Fig. 2e). Moreover, MACS+ cells cultured on STO cells demonstrated stable, periodic Ca2+ 
oscillation over time (Fig. 2f and Supplementary Video 1) and its average frequency (0.241 ± 0.048 Hz) was in the 
range of previous studies18,21,37–39. Our results suggest that the STO culture system facilitates proliferation of not 
only MACS+ cells but also P-MACS+ cells over time while preserving their pacemaker activities.
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Application of MACS+ cells cultured on STO cells. ICC residing in the intestinal smooth muscle 
tend to align along the smooth muscle orientation40–43 (Supplementary Fig. 3a). In order to induce the proper 
alignment, MACS+ cells were cultured on STO-seeded electrospun poly(3-caprolactone) (ePCL) scaffolds40 
(Supplementary Fig. 3b). MACS+ cells proliferated and aligned along the ePCL fiber orientation after 2 weeks 
(Fig. 3a). Coherency analysis of Kit expression confirmed that MACS+ cells cultured on ePCL scaffolds (aligned) 
were statistically more aligned (0.445 ± 0.021 vs. 0.087 ± 0.022) than those cultured on glass (random orientation) 
controls (Fig. 3b,c). Further, we demonstrated that MACS+ cells (GFP+) survived for at least a week in vivo, 
following colonoscopic injection into the rectal submucosa of C57BL/6 mice. Injected MACS+ cells, identified 
by GFP, co-localized with Ano1 expressed by ICC but not with α-SMA (Fig. 3d,e). Moreover, MACS+ cells were 
distributed around the injection site of the submucosa as indicated by carbon ink and demonstrated alignment 
along the smooth muscle layer, accompanied by native ICC and SMCs (Fig. 3d,e). Minimal inflammation was 
noted at the site of cell injection. These results demonstrate that the in vitro expanded ICC not only can be align 
by using scaffolds but also can survive in vivo through colonoscopic injections.
Figure 1. Maintenance of MACS+ cells cultured on STO cells. (a) Confocal images of ICC markers, Kit (red), 
Ano1 (green), and co-localization (yellow). 60 k MACS+ and 15 k MACS+ cells were cultured for 7 days and 
14 days respectively. Scale bar, 100 µm. (b) MACS+ cells were analyzed for Kit mRNA expression (b–d: day 
1, 4, 7 n = 4; day 14 n = 2). (c,d) GFP + MACS+ cells were seeded on STO cells, MEF, and Ge, cultured, and 
analyzed for mRNA expression of Kit (c) and gfp DNA (d). STO cells and MEF do not express Kit/gfp. (e) 
mRNA expression of Kit for MACS+ cells cultured on STO cells, MEF and Ge for 7 days. (f) mRNA expression 
of Kit for MACS+ cells cultured on different STO seeding densities for 7 days, where 100% is 100 k (100%, 
n = 5; 50%, n = 4; 25%, n = 2). (g) mRNA expression of Kit for MACS+ cells cultured on Ge for 7 days in media 
supplemented with 25, 50, or 100 ng/ml of soluble scf (n = 2). STO and Ge were controls (n = 5). (h) mRNA 
expression of Kit for 60 k or 15 k MACS+ cells cultured on Ge for 7 days supplemented with conditioned 
media from STO (Ge-CM), where Ge was the control (n = 4). STO = Mouse Embryonic Fibroblfast (Sandos 
Inbred Mouse, SIM). MEF = Mouse Embryonic Fibroblast (C57BL/6). Ge = gelatin coating. Feeder cells (STO, 
MEF) were mitomycin C treated. *Samples were normalized to de-epithelialized intestine. Error bars, s.d. 
***P < 0.0001, *P < 0.05.
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ISMC Mix and MOVAS cells maintenance on STO cells. To test whether our approach of culturing 
MACS+ cells with spontaneous Ca2+ oscillation could support periodic contractions of SMCs, ISMC Mix was 
cultured on STO cells for three weeks. At day 7, ISMC Mix cultured on STO cells in F12 medium expressed 
the highest level of ICC markers (Kit and Ano1 co-localization), SMCs marker (MHC) and neuronal marker 
(β-tubulin), followed by ISMC Mix cultured on STO cells in FBS medium and ISMC Mix cultured on gelatin in 
FBS medium (Fig. 4a). Comparable to the trends observed in immunostaining, ISMC Mix on STO cells cultured 
in F12 medium showed the greatest expression of Kit, Myh11, Tubb3, Kitl, and Acta2 up to three weeks, with the 
exception that cells cultured on STO cells in FBS medium had a slightly higher expression of Kitl at weeks two 
and three (Fig. 4b). Cells cultured on STO cells had higher expression of Kit and Kitl (STO-FBS vs. Ge-FBS) while 
F12 medium induced higher expression of Myh11, Tubb3, and Acta2 (STO-F12 vs. STO-FBS) (Fig. 4b). Cultures 
with STO cells and F12 medium demonstrated the greatest expression of Myh11 over time (Fig. 4b). ISMC Mix 
cultured on gelatin had a higher proliferation but lower expression of other markers compared to ISMC Mix 
cultured on STO cells with FBS or F12 medium (Fig. 4b). We also cultured a vascular aortic smooth muscle cell 
line (MOVAS cells) under the same conditions as ISMC Mix to study the effects of our system on non-intestinal 
SMCs. MOVAS cells followed a similar trend as ISMC Mix; they were enriched in mature SMC marker, Myh11, 
on day 7, with the best condition being F12 medium on STO cells (9.75 ± 0.969) and the worst being on gelatin 
(5.51 ± 0.735) (Fig. 4d). This finding suggests that the beneficial effects of our system on SMCs are not limited to 
ISMC Mix cells.
As predicted from the immunostaining and mRNA expression, ISMC Mix cultured on STO cells demon-
strated periodic contractions (Fig. 4c) while cells cultured on gelatin in FBS medium did not contract (not 
shown). STO cells with F12 medium enabled ISMC Mix to retain faster frequency over a longer period of time 
(0.252 ± 0.050 vs. 0.191 ± 0.054 at day7; 0.246 ± 0.046 vs. 0.112 ± 0.082 at day21) compared to ISMC Mix cul-
tured on STO cells in FBS medium (Fig. 4c). STO cells were shown to be effective in maintaining not only func-
tional ICC but also functional ISMC. Overall, these results suggest that STO cells with F12 medium is the optimal 
condition to culture ISMC Mix with periodic contractions (Supplementary Videos 2 and 3).
Engineering functional intestinal smooth muscle. To create an implantable tissue construct for regen-
erative medicine, we engineered intestinal smooth muscle with proper alignment and functionality by cultur-
ing ISMC Mix on STO-seeded ePCL in F12 medium. ISMC Mix cultured on STO-seeded ePCL demonstrated 
unceasing, rhythmic contraction over 10 weeks in vitro (Fig. 5f). After 10 weeks of culture, the constructs were 
Figure 2. Maintenance of passaged MACS+ cells on STO cells and rhythmic pacemaker activity of cultured 
ICC (MACS+ and passaged MACS+ cells). 60 k sorted cells were cultured for 7 days unless otherwise noted. 
(a) Immunofluorescence of passaged MACS+ (P-MACS+) cells with ICC markers, Kit (red) and Ano1 (green) 
and with co-localization (yellow). MACS+ cells were cultured on STO cells for 7 days and were passaged and 
sorted with MACS (P-MACS+). P-MACS+ cells were subsequently cultured on STO cells. Scale bar, 200 µm. 
(b,c) Growth comparison of GFP + MACS+ and P-MACS+ cells with mRNA expression of Kit (b) and DNA 
expression of gfp (c). (b,c: day 1, 4, 7 n = 4; day 14 n = 2). (d–f) Oscillations in intracellular Ca2+ concentration 
demonstrated the rhythmic pacemaker activity in MACS+ and P-MACS+ ICC cultures and their frequency 
were measured. (d) Ca2+ oscillation frequency of MACS+ cells cultured on STO cells or Ge at day 7 (n ≥ 5). 
(e) Ca2+ oscillation frequency of 60 k MACS+ and 60 k P-MACS+ cells cultured on STO cells at day 7, and 
the frequency of 15 k MACS+ cells cultured on STO cells at day 14 (n ≥ 5). (f) Representative time-course 
change in fluorescence intensity due to Ca2+ oscillation of ICC in the culture of MACS+ cells on STO cells 
at day 7 (Supplementary Video 1). *Samples were normalized to de-epithelialized intestine. Error bars, s.d. 
***P < 0.0001, *P < 0.05.
www.nature.com/scientificreports/
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examined with immunostaining and qPCR, demonstrating expression of ICC, SMC and neuronal markers, and 
more than 3 fold cell growth with gfp DNA (Fig. 5a,b). Although STO cells played essential roles in supporting 
ISMC Mix culture, the effect of STO cells likely declined over time due to its mitomycin C treatment. When STO 
cells were seeded alone, the reduction in the cell number and viability were observed over time (Supplementary 
Fig. 4).
To quantify the intensity and directionality of the periodic contractions generated by ISMC Mix on ePCL 
scaffolds, the dimensions of the most contracted scaffold was compared to those in the most relaxed scaffold 
(normalized to 1). The change in area of the scaffold (0.943 ± 0.004 vs. 1.00 ± 0.005) (Fig. 5d) was mainly due to a 
significant change in the length of the scaffold along the direction of the fibers, labelled as the height of the ePCL 
scaffold (0.955 ± 0.010 vs. 1.00 ± 0.005) (Fig. 5e). Moreover, the cells cultured on ePCL scaffolds showed surface 
alignment along the direction of the fibers in the scaffold (Fig. 5a,c). The alignment of ISMC Mix inside the ePCL 
scaffolds was also quantified as we had previously described40. Briefly, ePCL scaffolds were cut in two orthogonal 
planes to expose cross section parallel or perpendicular to ePCL’s aligned fibers. Coherency analysis (MHC, GFP 
and β-tubulin) and circularity analysis (DAPI) were used to compare the alignment in the two cross sections, 
where coherency factor ranges from 0 (perfect random) to 1 (perfect alignment) indicating cell alignment while 
circularity factor ranges from 0 (most elongated shape) to 1 (perfect circle) indicating elongation of nuclei due 
to cell alignment. Our results showed that the ISMC Mix cells infiltrated inside the ePCL and arranged along 
the ePCL’s aligned fibers (Supplementary Fig. 5). Culturing ISMC Mix on STO-seeded ePCL produced intesti-
nal smooth muscle constructs with proper alignment and spontaneous rhythmic contractions (Supplementary 
Video 4).
ICC is essential for rhythmic contraction of ISMC Mix. To confirm the role of ICC in ISMC Mix in pro-
ducing spontaneous, rhythmic contractions, MACS+ cells were separated from ISMC Mix to create a MACS− 
cells population that contains few ICC. The MACS− cells were cultured on STO cells for 3 weeks in vitro, and 
its motility, gene and protein expression were analyzed. The comparison between passaged ISMC Mix (MACS0) 
and MACS− cells showed that the ICC population in MACS0 is essential for spontaneous rhythmic contrac-
tions (Fig. 6a–c). MACS− cells, without an ICC population (Kit 1.79 ± 0.445 vs. 0.013 ± 0.005), failed to exhibit 
rhythmic contractions (0.246 ± 0.006 Hz vs. 0.064 ± 0.003 Hz at week3) even though SMCs (Myh11 0.575 ± 0.197 
vs. 1.10 ± 0.245) and neuronal cells (Tubb3 2.32 ± 0.586 vs. 4.01 ± 0.539) were present (Fig. 6a–c, MACS0 vs. 
MACS−). We also performed a rescue experiment where MACS+ cells were added back to MACS− cells 5 days 
Figure 3. Application of MACS+ cells cultured on STO cells. (a) Confocal images of ICC markers, Kit (red), 
Ano1 (green), and co-localization (yellow). 15 k MACS+ cells were cultured on STO-seeded ePCL scaffold for 
14 days. Scale bar, 100 µm. (b,c) Quantification of Kit alignment expressed by 15 k MACS+ cells cultured on 
STO-seeded ePCL and glass for 14 days. (b) Immunofluorescence of ICC markers, Kit (red) and Ano1 (green) 
and with co-localization (yellow). Scale bar, 200 µm. (c) Coherency analysis of Kit expression of MACS+ cells 
cultured on ePCL(aligned) and glass (random), where higher coherency means greater cell alignment (n = 5). 
(d,e) GFP + MACS+ cells were cultured on STO cells for 4 days and purified using MACS before colonoscopic 
injection into the submucosa of the rectum of C57BL/6 mice. A permanent carbon ink was mixed into the cell 
suspension to mark injection sites. The injected rectums were retrieved after 7 days, and were immunostained 
for Ano1 (d, red), α-SMA (e, red) and GFP (d,e, green). GFP co-localized with Ano1 (d, yellow) but not with 
α-SMA (e). Merged immunofluorescence images (left) were further merged with phase contrast images to show 
the area of injection indicated by black ink (right). Scale bar, 100 µm. Insets, higher-magnification images of 
boxed regions. Scale bar, 10 µm. Error bars, s.d. ***P < 0.0001.
www.nature.com/scientificreports/
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after they were cultured on STO cells (MACS−/+). The added MACS+ cells restored the rhythmic contractions 
of the MACS− cells cultured on STO cells in 5 weeks (0.230 ± 0.017 Hz vs. 0.056 ± 0.021; Kit 2.15 ± 0.297 vs. 
0.032 ± 0.010; Myh11 0.119 ± 0.019 vs. 0.179 ± 0.127; Tubb3 1.46 ± 0.378 vs. 1.97 ± 1.15) (Fig. 6d–f, MACS−/+ 
vs. MACS−). This experiment confirms that ICC play an essential role in producing the spontaneous rhythmic 
contractions of cultured ISMC.
Discussion
This study demonstrates that STO cells can support ICC in culture and maintains the spontaneous intracellular 
Ca2+ oscillation frequency within the previously published range16,18,26,37–39,44–46. These functional ICC pace the 
rhythmic contractions of SMC. It is also necessary for SMC to retain its maturity and express MHC to contract12,13 
upon receiving pacemaker signals from functional ICC. The loss of maturity and functionality of either ICC or 
SMC in culture is a major challenge for intestinal smooth muscle engineering12,13,47. Our system described here 
is an approach to achieving this goal by maintaining the functionality of both ICC and SMC, as well as neuronal 
cells cultured in vitro.
This system provides an easily accessible in vitro model to investigate the molecular mechanisms underlying 
a functional smooth muscle. The combination of STO cells and F12 medium works well to produce the in vitro 
culture of the intestinal smooth muscle. While it is likely that STO cells provide signals including preferable forms 
of SCF48,49 and other factors30 important for ICC to survive and function, the exact mechanisms that underlie 
Figure 4. Maintenance of intestinal smooth muscle cell mixture (ISMC Mix) and vascular aortic smooth 
muscle cell line (MOVAS cells) cultured on STO cells in vitro. Non-sorted cells from enzymatically digested 
intestinal muscle strips were used as ISMC Mix. All ISMC Mix and MOVAS cells were cultured separately in 
FBS medium for the first 4 days followed by FBS or F12 medium. (a–c) 100 k ISMC Mix were cultured on STO 
cells or Ge with FBS or F12 medium for up to 3 weeks. (a) Immunofluorescence of ISMC Mix with ICC markers 
showing co-localization (yellow) of Kit (red) and Ano1 (green), SMCs marker MHC (red), and neuronal 
marker β-tubulin (green) at day 7. Scale bar, 100 µm. (b) GFP + ISMC Mix were analyzed for mRNA expression 
(Kit, Myh11, Tubb3, Kitl, and Acta2) and gfp DNA (n = 3). (c) Spontaneous contraction demonstrated the 
functionality of ISMC Mix cultured on STO cells with FBS or F12 medium (Supplementary Video 2 and 3) and 
frequency was measured (n ≥ 5). (d) MOVAS cells were analyzed for mRNA expression (Myh11) at day 7 (n = 3; 
triplicate samples). FBS = 15% FBS in DMEM. F12 = advanced DMEM/F12. *Samples were normalized to de-
epithelialized intestine. **Samples were normalized to 100 k cells from day 0. Error bars, s.d. ***P < 0.0001, 
*P < 0.05.
www.nature.com/scientificreports/
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these observations will need to be investigated further. The beneficial effects provided by STO cells are important 
during the initial phase of the smooth muscle cell culture. It is likely that other cell types within ISMC Mix even-
tually take over the function of STO cells due to the mitomycin C treatment.
This novel culture method is likely to have broad applications. We demonstrated that both MACS+ cells and 
ISMC Mix were able to attach and align along ePCL scaffolds and that MACS+ cells cultured using our system 
survived in vivo after colonoscopic injections. Specifically, colonoscopic injections of ICC may help motility dis-
orders including diabetic gastroparesis, pseudo-obstruction and Hirschsprung’s disease due to frequent defects 
in ICC networks reported in those disorders33,34. The culture method could also be applied to cells from other 
visceral organs35, and the cultured cells could be seeded on other biomaterials, used in other in vivo studies, and 
incorporated into microfluidic systems.
Finally, this culture system is simple and reproducible for generating a functional smooth muscle layer in vitro. 
Our STO cell system only requires standard culture medium without specialized additives. STO cells are readily 
available at a low cost from commercial vendors. We believe that the STO cell system has the potential to become 
a common method to create functional smooth muscle in vitro. Our data demonstrate that the system sustains the 
maturity of the vascular smooth muscle cells, so it may similarly serve as the platform for both basic and applied 
research in various other types of smooth muscle functionalities and disorders.
Figure 5. Engineering aligned intestinal smooth muscle with periodic contraction over 10 weeks in vitro. 
100 k ISMC Mix were cultured on STO cells seeded ePCL scaffolds in FBS medium for the first 4 days before 
changing to F12 medium. (a) Confocal images of ISMC Mix with ICC markers showing co-localization (yellow) 
of Kit (red) and Ano1 (green), SMCs marker MHC (red), neuronal marker β-tubulin (green), and GFP (green) 
at 10 weeks. Scale bar, 100 µm. (b) GFP + ISMC Mix were analyzed for mRNA expression (Kit, Myh11, Tubb3, 
Kitl, and Acta2) (n = 5) and gfp DNA (n = 4). The dashed line indicates the seeding density. (c–e) Relaxed and 
contracted state comparison of engineered intestinal smooth muscle. (c) Images of GFP expression from ISMC 
Mix seeded ePCL scaffold were extracted from a video recording and outlined (relax, black; contract, gray) for 
comparison. Scale bar, 2 mm (Supplementary Video 4). (d) To show the degree of the periodic contraction, 
area of contracted ePCL scaffolds were normalized to that of relaxed ePCL scaffolds (n = 10). (e) To show the 
directionality of the periodic constriction, height and width of contracted ePCL scaffolds were normalized to 
those of relaxed ePCL scaffolds (n = 10). (f) Frequency of ePCL rhythmic contractions (n = 4). The dark gray 
dashed line indicates the mean frequency over time and light gray dashed lines indicate its s.d. *Samples were 
normalized to de-epithelialized intestine. Error bars, s.d. ***P < 0.0001, *P < 0.05.
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Figure 6. MACS+ cells’ role in cultured ISMC Mix with rhythmic contractions in vitro. (a–c) 100 k MACS0 
(passaged ISMC Mix: mixture of MACS+ cells, SMCs and neuronal cells) or MACS− cells (ISMC Mix without 
MACS+ cells: mostly SMCs and neuronal cells) were cultured on STO cells for 3 weeks. Cells were seeded 
and cultured in FBS medium for the first 4 days before changing to F12 medium. (d–f) 100 k MACS− were 
seeded on STO cells for 5 weeks, with (MACS−/+) or without (MACS−) addition of 60 k MACS+ cells on 
day 5. Cells were cultured in FBS medium for the first 7 days before changing to F12 medium. (a,d) Confocal 
images of ICC markers, Kit (red), Ano1 (green), co-localization (yellow). Scale bar, 100 µm. (b,e) Frequency of 
cultured cells motility due to spontaneous contraction (b: wk2 n = 2, wk3 n = 4; (e) wk5 n = 4). (c,f) Cultured 
cells were analyzed for mRNA expression (Kit, Myh11, Tubb3) at week 2 (c) or week 5 (f) (n = 4). *Samples were 
normalized to de-epithelialized intestine. Error bars, s.d. ***P < 0.0001, **P < 0.01, *P < 0.05.
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Methods
Electrospinning. 11% (w/w) solution of PCL (Durect Lactel, Birmingham, AL) was made in hex-
afluoro-2-propanol (Acros Organics, Thermo Fisher Scientific, Waltham, MA). The solution was kept on a shaker 
overnight to obtain a homogenous polymer solution. The mandrel was wrapped with aluminum foil to ease the 
removal of the scaffold. The PCL solution was transferred to a plastic syringe fitted with an 18-gauge needle, and 
secured onto a syringe pump (Harvard Apparatus, Holliston, MA). The solution was infused at 2.5 ml/h onto a 
rotating mandrel collector with an outer diameter of 32 mm that was positioned 12–15 cm away from the needle 
tip. The electrical potential difference between the needle (i.e., polymer solution) and the grounded mandrel 
collector was produced by a high voltage power supply (Glassman High Voltage, High Bridge, NJ). Scaffolds com-
prised of aligned ePCL fibers were fabricated using a mandrel rotational speed of 3450 rpm and an applied voltage 
of 15 kV. Less-aligned, “random” ePCL fibers were produced using a mandrel rotational speed of 1725 rpm and 
applied voltage of 25 kV. After 0.5 ml of polymer solution had been dispensed from the syringe onto the rotating 
mandrel, the ePCL was carefully removed from the aluminum foil. Scaffolds were air-dried before laser cutting.
Laser cutting. ePCL scaffolds were constructed as fiber sheets with dimensions approximately 10 × 2.5 cm 
and thickness of 100–150 µm, based on the mandrel used. These fiber sheets were cut into rectangular 8 × 6.5 mm 
scaffolds using the VERSA LASER CUTTER 2.3 (Universal Laser Systems, Scottsdale, AZ) with vector mode, 5% 
power, 100x speed, and 1000 pulses/inch. Scaffolds were obtained by setting the longer edge of the rectangle to be 
along the fiber direction. The scaffolds were cleaned with air plasma (Harrick Plasma, Ithaca, NY) at 500 mTorr, 
high power for 1 min and subsequently sterilized with strong UV (Dymax) for 1 min. The scaffolds were washed 
once with phosphate buffered saline (PBS) (Invitrogen, Carlsbad, CA) before and after coating with gelatin solu-
tion (attachment factor solution (AF); Invitrogen) at 37 °C for at least 30 min. (Note: To improve the cell seeding 
onto ePCL scaffolds, PDMS molds with a well size the same as an ePCL scaffold were manufactured. This will 
allow ePCL scaffold to fit perfectly and stay at bottom of the PDMS well so that seeded cells attached effectively on 
the ePCL scaffold with minimal spillage to the bottom of the well).
Scanning Electron Microscopy (SEM). The surface morphology of ePCL scaffolds with aligned or ran-
dom fibers was assessed using a Nova NanoSEM 230 (FEI, Hillsboro, Oregon). The scaffolds without conductive 
coating were mounted on the sticky conductive carbon tape (Ted Pella, Redding, California) on the top of alu-
minum stubs (Ted Pella, Redding, California) and examined under SEM with an accelerating voltage of 10 kV at 
low vacuum mode.
Ethics statement. Animal usage complied with regulations set by the University of California, Los 
Angeles, Chancellor’s Animal Research Committee and was approved as animal protocol number 2005-169. 
All efforts were made to minimize pain and suffering. Two mice strains were used for these experiments: 
C57BL/6-Tg(Actb-EGFP)1Osb/J (“GFP”) (The Jackson Laboratory, Bar Harbor, ME) and wild type C57BL/6 
(Charles River, Wilmington, MA).
Feeder cells preparation. Embryonic fibroblasts, STO (SIM, Sandos Inbred Mouse) and MEF (C57BL/6) 
(both from ATCC) were expanded in STO medium (low glucose DMEM with GlutaMAXTM supplemented with 
10% FBS and 1x ABAM (All Invitrogen)) and suspended in STO medium with 10% DMSO for cryopreserva-
tion (~106 cells/ml, 1 ml/vial). ~106 feeder cells were thawed and cultured in gelatin coated T25 flasks with STO 
medium for a few days until confluency and treated with mitomycin C (Sigma). ~100 k cells were seeded onto 
gelatin-coated substrates such as 48-well plate (Coring Costar, Fisher Scientific), eight-chamber slide (Nunc™ 
Lab-Tek™ II; Thermo Scientific) and ePCL scaffold, and cultured at 37 °C with STO medium in a 10% CO2 incu-
bator. Prepared feeder cells were used within 3 days.
Primary intestinal smooth muscle cell mixture (ISMC Mix) isolation and culture. ISMC Mix were 
isolated from 7 to 10-day-old C57BL/6 neonates using previously described methods12,38,40,50. The intestines were 
removed via a midline incision, and smooth muscle strips, containing both longitudinal and circular muscle lay-
ers, were gently teased from the intestines using fine forceps and placed in Hank’s Balanced Salt Solution (HBSS) 
without calcium and magnesium (Invitrogen, Carlsbad, CA) with 1x antibiotic-antimycotic (ABAM) (Invitrogen) 
on ice. Then the smooth muscle strips were minced and incubated at 37 °C for 30~40 min in an enzyme solution 
containing collagenase (1.3 mg/ml Worthington Type II; Worthington Biochemical, Freehold, NJ), bovine serum 
albumin (BSA) (2 mg/ml), trypsin inhibitor (2 mg/ml), ATP (0.27 mg/ml) (all from Sigma, St. Louis, MO), and 
10% HBSS with calcium and magnesium (Invitrogen) in HBSS without calcium and magnesium containing 1x 
ABAM. The tissue was washed twice with vigorous pipetting with 10% FBS in HBSS without calcium and magne-
sium containing 1x ABAM. As a preparation for immunomagnetic sorting (MACS), the resulting ISMC Mix was 
cultured in gelatin coated T25 flasks (ISMC Mix from ~4 pups in one T25 flask) for 3 days. Alternatively, 100 k 
ISMC Mix were seeded onto substrates (48 well plate, eight-chamber slide, ePCL scaffold) with STO cells or gela-
tin coating. ISMC Mix were cultured at 37 °C in a 5% CO2 incubator in FBS medium (Knockout™ D-MEM sup-
plemented with 15% ECS-qualified FBS, 0.1 mM MEM Non-Essential Amino Acids solution, 2 mM L-glutamine, 
0.1 mM 2-mercaptoethanol, 1x ABAM, and 10 mM HEPES (Invitrogen)). All ISMC Mix were cultured in FBS 
medium for the first 4 days followed by FBS or F12 medium (Advanced DMEM/F-12 supplemented with 2 mM 
L-glutamine, 1x ABAM, and 10 mM HEPES (Invitrogen)). For conditioned medium (CM) preparation, STO 
medium was replaced with FBS medium after the STO cells formed a confluent monolayer and treated with mito-
mycin C. The FBS medium was collected after 4~5 days of incubation, passed through a 0.2 μm pore size filter 
(Pall Corporation, Port Washington, NY), and mixed with fresh FBS medium (1:1 ratio) as CM. The medium was 
changed every 2~3 days.
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MOVAS cell culture. MOVAS cells (C57BL/6) (ATCC) were expanded in STO medium and suspended in 
STO medium with 10% DMSO for cryopreservation (~106 cells/ml, 1 ml/vial). ~106 feeder cells were thawed and 
cultured in gelatin coated T25 flasks with STO medium for a few days until confluency. ~100 k cells were seeded 
onto 48-well plate (Coring Costar, Fisher Scientific) with STO cells or gelatin coating in triplicates. All MOVAS 
cells were cultured in FBS medium for the first 4 days followed by FBS or F12 medium.
Enrichment of ICC by immunomagnetic sorting (MACS). After 3 days in culture, ISMC Mix were 
washed in PBS and incubated with 0.05% trypsin-EDTA (Invitrogen) at 37C for ~2 min The ICC marker, Kit, 
the epitope recognized by ACK2, is easily altered or masked during the enzymatic digestion process. Therefore, 
it is important to avoid over-digestion. The reaction was stopped by adding FBS medium. The dissociated cells 
were washed once with sorting buffer (1% BSA (Fisher Scientific) and 2 mM EDTA (Sigma) in PBS; ~pH7.2) 
and passed through a 100 µm cell strainer (Fisher Scientific). After centrifuging the cell suspension at 1000 rpm 
for 5 min, supernatant was aspirated completely. The cell pellet was re-suspended in sorting buffer and then 
well-mixed with the CD117 MicroBeads solution (Miltenyi Biotec, Germany; 1:5 in sorting buffer). The cell sus-
pension was incubated for 15 minutes at 4 °C. For cells from four pups, 160 µL of sorting buffer and 40 µL of 
CD117 MicroBeads solution were used. Half the volume was used for cells isolated from two pups. The cell 
suspension was mixed with pipetting every 5 min. After being washed twice with the sorting buffer, the labeled 
cells were re-suspended in sorting buffer and 0.5 ml of the cell suspension was passed through pre-wetted MS 
magnetic columns placed in a strong magnet (MiniMACS; Miltenyi Biotec) at a time. Cells from four pups were 
re-suspended in 4 ml sorting buffer and passed through two MS columns, 2 ml per each. After passing all of the 
cell suspension, MS columns were washed once with 1 ml of sorting buffer. Unlabeled cells were collected as 
flow-through (MACS− cells), while labeled cells retained in the columns were flushed out with 1 ml of sorting 
buffer after removing the column from the magnet (MACS+ cells). MACS+ cells were seeded onto gelatin or 
feeder cells and cultured at 37 °C, 10% CO2 incubator in FBS medium.
For P-MACS culture, the resultant MACS+ cells from 4 pups were all cultured on a STO-seeded well of 
a 6-well plate for 7 days, passaged with MACS, and subsequently cultured on STO cells in FBS medium. The 
medium was changed every 2~3 days.
For MACS0, MACS− and MACS−/+ culture, CD117 MicroBeads labeled cells without passing through the 
MS magnetic column (MACS0) and MACS− cells were cultured on STO cells in FBS medium for 4 days followed 
by F12 medium. We also added MACS+ cells back to MACS− cell culture 5 days after they were cultured on 
STO cells in order to recover its spontaneous contractility (MACS−/+). The MACS−/+ cells were cultured in 
FBS medium for 7 days, followed by F12 medium (2 days after adding the MACS+ cells onto MACS− cells). The 
medium was changed every 2~3 days.
Measurement of pacemaker activity in purified ICC (MACS+ cells). To monitor oscillations in 
intracellular Ca2+ concentration, cultured ICC (MACS+ cells) were incubated with 1 part of 2X Fluo-4 Direct™ 
calcium reagent loading solution without probenecid (Invitrogen) and 1 part of FBS medium at 37 °C, 5% CO2 
incubator for 0.5~1 hour. Incubating for too short of a time will result in a weak signal while too long will result in 
an increased number of floating dead cells. Fluorescent images (680 × 512 pixels) were acquired with an Olympus 
IX71 microscope using cellSens software (Olympus, Center Valley, PA) (acquisition rate: 4.8~7.7 Hz; excitation 
wavelength: 494 nm; emission wavelength: 516 nm), and analyzed using custom MATLAB programs12 (region 
of interest analysis, Supplementary Fig. 6; fast-forward and gray scale normalization, Supplementary Fig. 7). In 
order to keep the temperature close to 37 °C51,52, cells were limited to 5 min at room temperature for image acqui-
sition and were returned to the incubator before repeating the process.
Colonoscopic injection of MACS+ cells cultured on STO cells. Eight to 12 week old male and female 
C57BL/6 J mice (n = 3) were placed on water only diet overnight. Anesthesia was induced with 3% isoflurane then 
decreased to 1% for maintenance. Colonoscopy was performed by introducing a lubricated 1.9 mm endoscope 
(Karl Storz, Tuttlingen, Germany) into the mouse rectum, as previously described53. GFP + MACS+ cells were cul-
tured on STO cells for 4 days and MACS purified prior to the colonoscopic injection. The resulting P-MACS+ cells 
were re-suspended in low glucose DMEM with GlutaMAXTM (Invitrogen) to a concentration of 5 × 105 cells/ml 
and mixed with 1.5% permanent carbon ink (Spot; GI Supply, Camp Hill, PA) for later identification of the injec-
tion sites. Using a 30 gauge custom-made needle fitted with pulled and beveled capillary tubing53, 100 µL of the 
cell suspension was injected into the submucosa of the ventral rectum (n = 12 total). Mice were monitored for 
appropriate recovery from anesthesia and placed back in standard laboratory mouse cages with full access to 
water and chow. All mice were sacrificed 7 days after the cell injection procedure and colon specimens were 
isolated.
Histology and immunofluorescence staining. Samples, including cell-seeded ePCL and P-MACS+ 
injected intestine, were formalin-fixed and processed for paraffin embedding. Serial 5 µm sections were cut 
and adhered to glass slides. Unstained slides were prepared for immunofluorescence staining. Slides were 
de-waxed with xylene and rehydrated with serial dilutions of ethanol. Next, slides were incubated in a citric 
buffer (Biogenex, San Ramon, CA) for 15 min at 95–100 °C and allowed to cool for 15 minutes in an over flowing 
water bath. In vitro cultures and native smooth muscle strips were fixed without histologic processing. For Kit 
and Ano1 staining, samples were fixed with acetone for 30 min at 4 °C. For all the other staining, samples were 
fixed with 10% formalin for 30 min at room temperature. After three washes with PBS, samples were treated with 
a blocking buffer containing 5% normal goat serum (Vector Labs, Burlingame, CA), 0.1% Triton X-100 (Sigma) 
in PBS for 1 hour at 4 °C. Samples were then incubated with the following primary antibodies: Kit (1:500; eBio-
science: 16-1172-82), Ano1 (1:500; Abcam: ab53212), MHC (1:100; Abcam: ab53219), β-tubulin (1:500; Abcam: 
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ab78078), GFP (1:500; Aves: GFP-1020), and SCF (1:500; ab64677) diluted in staining buffer containing 5% nor-
mal goat serum in PBS overnight at 4 °C. After two washes in PBS, samples were incubated in the dark with their 
corresponding Alexa Fluor® secondary antibodies (1:500; Invitrogen) and Alexa Fluor® 594 Palloidin (1:100; 
Invitrogen) diluted in staining buffer for 2~3 hours at room temperature. After three washes with PBS, Prolong 
Gold with DAPI (Invitrogen) was applied to each section and the slides were covered with glass coverslips. The 
slides were allowed to cure at 4 °C before storing at −80 °C. Fluorescent images were acquired with an Olympus 
IX71 microscope with cellSens software (Olympus, Center Valley, PA) or confocal laser microscopy (TCS SP2 
AOBS, TCS SP2 MP AOBS; Leica).
DNA/RNA extraction and qPCR. DNA and RNA were extracted and purified from in vitro cul-
tures using the DNeasy and RNeasy kits (Qiagen, Valencia, CA), respectively following the manufacture’s 
protocol. RNA samples were cleaned with RNase-Free DNase set (Qiagen) during the procedure. The qPCR 
reactions were prepared using a PCR master mix and the Quantitect Probe RT-PCR Kit (Qiagen) and per-
formed on an ABI 7500 Real Time PCR System (Applied Biosystems). The primers and probe for gfp-DNA 
and Kit-RNA were custom- designed and purchased from Eurofins MWG Operon, (Huntsville, AL): gfp-fw, 
5′-ACTACAACAGCCACAACGTCTATATCA-3′; gfp-rev, 5′-GGCGGATCTTGAAGTTCACC-3′; gfp-pb, 
and 5′-[6-FAM]CCGACAAGCAGAAGAACGGCATCA[TAMRA-Q]-3′; Kit-fw, 5′-CCGTGAACTCC 
ATGTGGCTAAAGA; Kit-rev, 5′-GGTGCCAGCTATTGTGCTTTACCT-3′; Kit-pb, 5′-[6-FAM]TGAACCC 
TCAGCCTCAGCACATAGC[TAMRA-Q]-3′. All the other primer/probe mixtures were purchased from 
Applied Biosystems: Myh11 (Mm00443013_m1), Tubb3 (Mm00727586_s1), Kitl (Mm00442972_m1), Acta2 
(Mm01546133_m1), Ano1 (Mm00724407_m1) and Gapdh (Mm99999915_g1). DNA qPCR results were ana-
lyzed using a standard prepared with known number cells from ISMC Mix. RNA qPCR results were analyzed 
using Gapdh as the housekeeping gene and de-epithelialized intestine from 7 to 10-day-old C57BL/6 neonates as 
reference. For MOVAS cells, 100 k cells from day 0 were used as reference.
MTS assay. MTS assay was conducted to test the viability of mitomycin C treated STO cells over time. 100 k 
mitomycin C treated STO cells were seeded on to 48-well plate in STO medium overnight, followed by the same 
series of medium as the preparation for ISMC Mix feeder layer. At each time point, wells with cells and without 
cells (control) were incubated with a mixture of CellTiter 96® AQueous One Solution Reagent (Promega) in 
appropriate medium (1:5 volume ratio) at 37 °C in a 5% CO2 incubator for an hour. The absorbance was measured 
at 490 nm (SynergyTM HT; BioTek). Data were normalized to controls.
Data Analysis. The frequency of spontaneous contractions of the cells was analyzed manually from recorded 
videos (680 × 512 pixels; acquisition rate: 5.0 Hz) acquired with an Olympus IX71 microscope using cellSens soft-
ware (Olympus, Center Valley, PA). The area, height and width of the most contracted ePCL scaffolds were nor-
malized to that of the most relaxed ePCL scaffolds with ImageJ using images extracted from a representative video 
and manually outlined ePCL scaffolds. In order to compare the size of feeder cells, area of MEF was normalized to 
that of STO cells with ImageJ. For the cell alignment quantification, ImageJ was used to conduct circularity anal-
ysis (DAPI) and the plugin OrientationJ was used to conduct coherency analysis (Kit, MHC, GFP and β-tubulin).
Statistical analysis. One-way ANOVA followed by Tukey test or two-tailed unpaired Student’s t-test 
was used depending on the number of simultaneous conditions to analyze. Levels of significance were set at 
***P < 0.0001, **P < 0.01, and *P < 0.05. Data were expressed as the mean ± the standard deviation (s.d.). n 
indicates the number of independent experiments (different primary cell isolations from different animals) except 
for the following cases: Fig. 2d,e, n = number of cell cultures (from 3 different independent experiments); Fig. 3c, 
n = number of images (from one independent experiment); Fig. 4c, n = number of videos (from two independent 
experiments); Fig. 5d,e, n = number of images (extracted from a representative video).
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